Primary Site >> Liver Cancer

Gene >> ATR

  • 1999
  • 2001
  • 2005
  • 2008
  • 2010
  • 2012
  • 2013
  • 2014
  • 2017
  • 2018
Ref: A novel sensitive method to detect frameshift mutations in exonic repeat sequences of cancer-related genes.
PMID: 10545425
Ref: Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.
PMID: 11691784
Ref: Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance.
PMID: 16103057
Ref: Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival.
PMID: 18440592
Ref: Growth inhibitory effect and Chk1-dependent signaling involved in G2/M arrest on human gastric cancer cells induced by diallyl disulfide.
PMID: 20401435
Ref: Pteridium aquilinum and its ptaquiloside toxin induce DNA damage response in gastric epithelial cells, a link with gastric carcinogenesis.
PMID: 22143989
Ref: Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
PMID: 23569343
Ref: Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line.
PMID: 25176258
Ref: AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells.
PMID: 28138034
Ref: Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network.
PMID: 29025585
Ref: Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.
PMID: 29144413
Ref: Chk1 activation attenuates sensitivity of lapatinib in HER2-positive gastric cancer.
PMID: 29271513
Ref: A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.
PMID: 30344100
Ref: pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
PMID: 30385821